Top news of the week: 20.10.2020.

#biopharma #biotechnology #biospace #lifesciences #pharmaceuticals #genetherapy #StateOfPossible #NobelPrize2020 #news #pharma

Career And Jobs

On Oct 19, 2020
@FierceBiotech shared
M&A activity still looks fairly lively in 2020 despite a somewhat subdued start as the industry adapted to the looming coronavirus pandemic. https://t.co/u7ZpDjIr71
Open

The top 10 takeover targets in biopharma

The top 10 takeover targets in biopharma

Most if not all large-cap pharma and biotech companies are still in need of business development as they work to rebalance their operations. Cancer, rare disease, and to a lesser extent ...

On Oct 15, 2020
@biospace shared
Biopharma Money on the Move: October 7-14 #biospace #lifesciences #biotechnology #pharmaceuticals #biopharma https://t.co/9x2rex1r6l
Open

Biopharma Money on the Move: October 7-14

Biopharma Money on the Move: October 7-14

Find out which life sciences companies are raking in the cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.

On Oct 16, 2020
@GENbio shared
.@OriBiotech raises $30 M in Financing. The new funding will help take their manufacturing platform to the market that delivers solutions to address the clinical and commercial manufacturing needs of cell and #genetherapy developers. Learn more: https://t.co/3KDStJHa7A https://t.co/FryA7W3zq3
Open

Ori Biotech Raises $30 Million in Financing

Ori Biotech Raises $30 Million in Financing

 Funds will be used to advance innovation in cell and gene therapy manufacturing.

On Oct 18, 2020
@NatureBiotech shared
RT @UMassMedical: Guangping Gao, PhD, & #NobelPrize2020 winner Jennifer Doudna are both on @NatureBiotech's list of top translational biotech researchers for 2019. The #genetherapy pioneer & director of @UMMSGeneTherapy was on the 2018 list too. https://t.co/DQLXMsOuro @nresearchnews #UMassMedNews
Open

Guangping Gao makes list of Nature Biotechnology Top 20 translational researchers

Guangping Gao makes list of Nature Biotechnology Top 20 translational researchers

An influential scientific journal’s list of top translational biotech researchers for 2019 includes Guangping Gao, PhD. Rankings are based on total patents for the year, among other ...

On Oct 15, 2020
@pharminews shared
Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing https://t.co/5cgcAngtEG #news #pharma #pharmiweb
Open

Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing

Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing

Syndicate led by leading life science investors Northpond Ventures alongside Octopus VenturesOctober 14, 2020, London, UK and Woodcliff Lake, NJ - Ori Biotech Ltd (Ori), a leading innovator ...

On Oct 16, 2020
@BioWorld shared
Australia’s device and biotech companies hold the key for future pandemic preparedness: MTPConnect report https://t.co/4fZ24cmvoK
Open

Australia’s device and biotech companies hold the key for future pandemic preparedness: MTPConnect report

Australia’s device and biotech companies hold the key for future pandemic preparedness: MTPConnect report

PERTH, Australia – During the COVID-19 pandemic, 90% of Australia’s clinical trials were put on hold, and the market cap of biotech and medical device companies on the Australian Securities ...

On Oct 16, 2020
@biospace shared
Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry #biospace #lifesciences #biotechnology #pharmaceuticals #3D #Bioprinting https://t.co/LHXSLKg1BA
Open

Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry

Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry

By using naturally-derived scaffolds, human cells and other biocompatible materials, 3D bioprinting has ushered in opportunities for researchers to design, print and optimize patient ...

On Oct 19, 2020
@MassBioEd shared
Episode 2 of @MassBio's #StateOfPossible Podcast is live! Join MassBio CEO @BobCoughlin & guests @KateWalshCEO, @The_BMC & @ChirfiG, @biogen as they discuss how #biopharma & providers can work together to address health inequities in the US. Listen: https://t.co/jzlaUDaVsK
Open

State of Possible Podcast – Episode 2: How Biopharma & Providers Can Work Together to Address Health Inequities

State of Possible Podcast – Episode 2: How Biopharma & Providers Can Work Together to Address Health Inequities

COVID-19 has put a spotlight on health inequities in our country, with minority populations being impacted at a disproportionate rate. In this episode, host Bob Coughlin and his guests, ...